7:03 am RedHill Biopharma provides update on RHB-102 development and intellectual property; co has secured from Temple University direct rights to the original RHB-102 patents and has terminated its agreement with SCOLR Pharma
View todays social media effects on RDHL
View the latest stocks trending across Twitter. Click to view dashboard